-
Elk Grove hospital hosts trials on potential new Alzheimer's treatments
16 Feb 2025 13:23 GMT
… conduct trials for the drug bapineuzumab, which wasn’t approved but …
-
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
10 Feb 2025 14:47 GMT
… treating Alzheimer’s disease was bapineuzumab, a humanized variant of anti …
-
What drugmakers did not tell volunteers in Alzheimer’s trials
24 Oct 2024 00:41 GMT
… failure involved a drug called bapineuzumab, known as bapi. Wall Street … ’s research “may hinge on bapineuzumab’s outcome.” Those hopes dimmed …
-
Prevention and Treatment Strategies for Alzheimer’s Disease: Focusing on Microglia and Astrocytes in Neuroinflammation
12 Oct 2024 13:53 GMT
… for oligomers, while others like bapineuzumab and solanezumab are intended for … aseptic meningitis.23,24 Both bapineuzumab and solanezumab encountered challenges in …
-
Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
18 May 2024 13:43 GMT
… , solanezumab from Eli Lilly, and bapineuzumab from Pfizer.113
Function of …
-
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
16 Feb 2024 15:36 GMT
… you’re making point between bapineuzumab and lecanemab and I think … . As you say with the bapineuzumab work, I think there is …
-
Alzheimer's treatments: The risks of monoclonal antibodies may…
23 Jan 2024 03:02 GMT
… to specific drugs.
The drug bapineuzumab was associated with a significant …
-
Monoclonal Antibodies May Cause Serious Harm for Patients with Alzheimer
23 Jan 2024 02:54 GMT
… to 1.56). The drug bapineuzumab was linked to a significant …
-
Are we REALLY at a 'turning point in the fight against Alzheimer's'? Breakthrough new drugs halt cruel disease's decline... but experts warn crippling side effects (and cost) may outweigh any benefits
18 Jul 2023 01:53 GMT
… of Alzheimer's drug bapineuzumab in 2012.
Roche halted two …